It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Discover well funded cryptocurrency projects and see which ventures led fundraising in recent years. Learn how strong backing signals confidence and growth potential.
17,705 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A high-stakes Senate hearing over Iran policy put the spotlight on intelligence briefings and political risk. The key...
As refined product margins surge, a veteran energy analyst says the bottleneck is refining capacity, not crude supply...
NVIDIA riding robust AI demand, elevated data-center spending, and resilient margins as 2026 unfolds. Analysts weigh ...
When Costco stock fell today after its June sales update, investors asked whether this is a temporary wobble or the s...
A sweeping change is quietly redefining housing. This article explains the $48t “structural shift” housing and why it...
Two leading cybersecurity ETFs are signaling different bets on digital defense. CIBR emphasizes software platforms, w...
As AI adoption accelerates, Uber cofounder Travis Kalanick’s ‘white pill’ view argues humans stay valuable until true...
A playful pop culture moment becomes a blueprint for smarter money choices. Learn actionable steps to budget, save, a...
Federal bank regulators announced a three-part plan to revise capital rules for mortgage assets, aiming to lift origi...
SK Hynix kicked off trading on Wall Street with a double-digit rally, marking the largest U.S. IPO by a foreign compa...
Nvidia has shown accelerating AI-driven demand that could push the stock higher. This article breaks down why the mar...